GlobeNewswire·Oct 29, 2026, 4:05 PM ET

Exponent Reports Third Quarter 2026 Financial Results

EXPO

Exponent, Inc. reported third quarter fiscal 2026 results ending October 2, 2026, with total revenues of $173.7 million (up 18%) & revenues before reimbursements of $153.1 million (up 12%).
Net income for the quarter increased to $30.9 million ($0.64 per diluted share) from $28.0 million ($0.55 per diluted share) in the prior year period.
EBITDA for the quarter reached $45.0 million, representing 29.4% of revenues before reimbursements, compared to $38.8 million (28.3%) in the prior year.
Year-to-date revenues before reimbursements totaled $453.7 million (up 11%), while net income reached $89.9 million ($1.83 per diluted share), up from $81.2 million ($1.58 per diluted share).
The engineering & scientific segment accounted for 85% of revenues before reimbursements, driven by user research & dispute-related services in chemical, consumer products, & transportation industries.
The environmental & health segment represented 15% of revenues before reimbursements, with growth driven by projects assessing chemical effects on health & the environment.
The company paid $46.1 million in dividends & repurchased $146.1 million of common stock during the first three quarters of 2026, ending with $114.7 million in cash.
Exponent announced a quarterly cash dividend of $0.31 to be paid on December 18, 2026, while raising full-year 2026 guidance for revenue growth to 10-11% & EBITDA to 28.0-28.3% of revenues before reimbursements.
Fourth quarter 2026 guidance anticipates revenue growth of 8-10% & EBITDA of 26.3-26.8% of revenues before reimbursements.
CEO Dr. Catherine Corrigan attributed growth to demand for integrated engineering expertise as digital & physical technologies converge, particularly in AI-enabled systems & critical infrastructure.
A conference call to discuss results was held on October 29, 2026, at 4:30 p.m. Eastern Time, with audio & webcast options available via company channels.